OPQ - Agilent OpenLab Software for Labs

The Food and Drug Administration is forecasting a procurement for OpenLab Software licenses under the OPQ laboratories program, aimed at supporting laboratory operations with Agilent’s OpenLab software solutions. The solicitation is classified under NAICS code 334614, which pertains to laboratory electronics and analytical instrument manufacturing, indicating the technical nature of the software requirements. The contract will be used to license the software to multiple laboratories under the agency’s oversight, likely to standardize data acquisition, analysis, and compliance across testing environments. The program point of contact for this opportunity is the Cder Acquisition Liaison, reachable via cderacquisitions@fda.hhs.gov, while the contracting officer’s details are still pending. The forecast was posted on May 25, 2026, and is currently unassigned to a specific set-aside category or geographic performance location. This opportunity is open for industry awareness and preparation, with no formal solicitation number issued yet. Interested vendors should monitor the official OSDBU portal for subsequent announcements, as the agency intends to acquire software licenses essential for regulatory and scientific laboratory workflows.